SKI Market

A+| A| A-|

Indian Indices

Sensex

74,532.96 325.72
( 0.44%)

Global Indices

Nasdaq

45,612.20 -430.24
(-0.93%)

Dow Jones

6,526.68 -100.81
(-1.52%)

Hang Seng

53,297.18 -1,942.22
(-3.52%)

Nikkei 225

9,927.54 -135.96
(-1.35%)

Forex

USD-INR

93.13 0.41
(0.44%)

EUR-INR

107.17 0.41
(0.39%)

GBP-INR

124.14 0.56
(0.45%)

JPY-INR

0.59 0.00
(0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Hikal Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524735

INE475B01022

96.8412723

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HIKAL

83.13

2080.7

EPS(TTM)

Face Value()

Div & Yield %

2.03

0.47

Back

Religare Enterprises consolidated net profit declines 24.35% in the September 2025 quarter

Nov 14,2025

Net profit of Religare Enterprises declined 24.35% to Rs 38.83 crore in the quarter ended September 2025 as against Rs 51.33 crore during the previous quarter ended September 2024. Sales declined 2.20% to Rs 249.46 crore in the quarter ended September 2025 as against Rs 255.06 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	249.46	255.06	-2
OPM %	24.40	29.76	-
PBDT	69.59	82.12	-15
PBT	57.45	67.44	-15
NP	38.83	51.33	-24

74,532.96 325.72 ( 0.44%)

45,612.20 -430.24 (-0.93%)

6,526.68 -100.81 (-1.52%)

53,297.18 -1,942.22 (-3.52%)

9,927.54 -135.96 (-1.35%)

93.13 0.41 (0.44%)

107.17 0.41 (0.39%)

124.14 0.56 (0.45%)

0.59 0.00 (0.73%)